Intended for UK patients and members of the public
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintProduct Documentation
Last updated on this site: 12 Aug 2026
Description of update: To update sections 4.3, 4.4, 4.5, and 4.8 of the SmPC in line with the reference products Prednisolone Pfizer 2.5 mg, 5 mg, and 10 mg tablets (MAH: Pfizer AB, MA Number: 10059, 8822, 10060). The PIL has also been updated accordingly. In addition, the following updates have been included: Editorial and formatting updates to the PIL; Update to lactose excipient information in the PIL to align with EC Excipient Guidelines; QRD update to SmPC section 4.4 and the PIL.
Date of approval: 11/08/2026
PIL sections updated: Headline, 2, 3, 4, 5 and 6
Last updated on this site: 12 Aug 2026
Description of update: To update sections 4.3, 4.4, 4.5, and 4.8 of the SmPC in line with the reference products Prednisolone Pfizer 2.5 mg, 5 mg, and 10 mg tablets (MAH: Pfizer AB, MA Number: 10059, 8822, 10060). The PIL has also been updated accordingly. In addition, the following updates have been included: Editorial and formatting updates to the PIL; Update to lactose excipient information in the PIL to align with EC Excipient Guidelines; QRD update to SmPC section 4.4 and the PIL.
Date of approval: 11/08/2026
SmPC sections updated: 4.3, 4.4, 4.5, 4.8 and 10
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintFor any further assistance, please get in touch.